Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis

Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis

To date, the impact of background glucocorticoids (GC) on the efficacy and safety of abatacept or adalimumab in patients with active rheumatoid arthritis (RA) is not clearly established. This post hoc analysis of (AMPLE) trial (NCT00929864) compared efficacy and safety outcomes over 2 years in patie...

Full description

Bibliographic Details
Main Authors: Yannick Degboé, Michael Schiff, Michael Weinblatt, Roy Fleischmann, Harris A. Ahmad, Arnaud Constantin
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
disease activity
rheumatoid arthritis
biologic DMARDs
Online Access:https://www.mdpi.com/2077-0383/9/6/2017

Internet

https://www.mdpi.com/2077-0383/9/6/2017

Similar Items